Partial Splenectomy in Children with Hereditary Spherocytosis
Jabali Y.1, Smrcka V.1, Chromčák F.1, Bäumelt V.2, Louda V.2
Detská klinika Nemocnice Ceské Budejovice, a.s.1 prednosta MUDr. V. Smrčka Chirurgické oddelení Nemocnice Ceské Budejovice, a.s.2 prednosta MUDr. V. Louda |
|
Summary:
Background: Though effective in the management of hereditary spherocytosis (HS),
total splenectomy (TSx) carries a life-long risk of OPSI despite preventive vaccination
and/or penicillin prophylaxis. The aim of this study is to verify whether partial splenectomy
(PSx) is quite effective and safe in managing HS in children.
Patients and methods: Upon informed consent, pts with moderate/severe HS were
immunized against encapsulated bacteria. PSx, with cholecystectomy (Cx) if need be,
was performed 1–6 wk later. Antibiotic therapy was given prn and revaccinationrecommended after 3–5 yr. One pt was excluded from analysis because of short followup
(FU). Another pt underwent elective TSx aged 6.6 yr. Mean Hb and mean absolute
reticulocyte count (ARC) during FU were assessed against respective preoperative
values in intent-to-treat (13) and as-treated (9) analysis. Moreover, the changes in
mean Hb and mean ARC were compared between successful PSx (9) and factual TSx
(5). Comparisons were made by t-test, with p<0.05 indicating significance. Morbidity,
quality of life, activity, and academic performance were systematically recorded.
Results: Between 02/96 and 02/07, 14 children (M:F = 8:6) with moderate or severe HS
underwent laparotomy with the intent of PSx with or w/o Cx. Their median age at operation
was 7.5 yr (range, 2.3–18.3; 11 pts >5 yr). PSx was indicated for anemia (8), cholecystolithiasis
(3), or both (3). Four children lost their spleen: due to technical infeasibility
of performing PSx (1), injury of the retained vascular pedicle (1), and for
spontaneous necrosis of the remnant in 2 and 18 months post-PSx (2). In 2 cases, 80 and
100 mL of sanguinolent fluid were drained from abdominal cavity. In 3 pts, 3 viral and
2 bacterial infections occurred. The median hospital stay was 8 d (range, 5–13). Regrowth
and/or activity of the remnant were demonstrated after successful PSx, however
w/o adversely affecting blood counts. In intent-to-treat analysis, mean Hb increased
from 99.4 to 137.8 g/L, while mean ARC decreased from 346,700 to 136,500/μL
(p=0.000001 for both). In as-treated analysis, mean Hb increased by 32 g/L (p=0.00002),
and mean ARC decreased by 182,300/μL (p=0.0001) post-PSx. However, PSx elicited less
spectacular changes than TSx: DHb 32 vs 50.2 g/L (p=0.01), and DARC 182,300 vs
309,000/μL (p=0.02). Nine pts were FU a median of 5.9 yr post-PSx (range, 4.8–10.4) for
a total of 54.8 pt.yr. Over that period, 43 febrile episodes, mostly viral upper RTI, were
encountered. Of the 2 hospitalizations for bacterial infection, 1 was on the parents’
wish, the other was in a pt with IBD. Nevertheless, antibiotics, most commonly broadspectrum
oral penicillin, were given in 23 cases. Except for 1 boy with IBD developing
>3 yr post-PSx and <2 yr post-Cx, all children managed perfectly, enjoyed normal physical
activity and performed well at school or work.
Conclusions: PSx combined with other measures appears to offer a reasonable alternative
to TSx in children with HS. However, more pts and longer FU are needed to fully
appreciate its true role in the management of this disorder.
Key words:
hereditary spherocytosis, splenectomy, overwhelming post-splenectomy
infection, children
|